Jane Street
NKTR icon

Jane Street’s Nektar Therapeutics NKTR Stock Holding History

Jane Street’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Buy
+49,400
New +$2.81M ﹤0.01% 4049
2025
Q4 		– Sell
-10,600
Closed -$603K – 11958
2025
Q3 		$603K Buy
+10,600
New +$351K ﹤0.01% 7449
2022
Q4 		– Sell
-1,300
Closed -$62K – 9795
2022
Q3 		$62K Sell
1,300
-1,687
-56% -$100K ﹤0.01% 8851
2022
Q2 		$170K Sell
2,987
-38,580
-93% -$2.43M ﹤0.01% 8311
2022
Q1 		$3.36M Buy
41,567
+39,260
+1,702% +$5.81M ﹤0.01% 3727
2021
Q4 		$467K Buy
2,307
+1,440
+166% +$312K ﹤0.01% 7400
2021
Q3 		$233K Sell
867
-1,926
-69% -$463K ﹤0.01% 8626
2021
Q2 		$719K Buy
+2,793
New +$773K ﹤0.01% 6529
2021
Q1 		– Sell
-2,333
Closed -$595K – 9428
2020
Q4 		$595K Buy
+2,333
New +$603K ﹤0.01% 5478
2020
Q3 		– Sell
-793
Closed -$276K – 7665
2020
Q2 		$276K Sell
793
-774
-49% -$242K ﹤0.01% 5958
2020
Q1 		$419K Buy
+1,567
New +$485K ﹤0.01% 3831
2019
Q4 		– Sell
-1,387
Closed -$379K – 5522
2019
Q3 		$379K Buy
+1,387
New +$509K ﹤0.01% 3883
2018
Q3 		– Sell
-2,107
Closed -$1.54M – 5509
2018
Q2 		$1.54M Buy
2,107
+1,367
+185% +$1.58M ﹤0.01% 2233
2018
Q1 		$1.18M Buy
740
+333
+82% +$429K ﹤0.01% 2451
2017
Q4 		$364K Buy
+407
New +$241K ﹤0.01% 3543
2017
Q2 		– Sell
-620
Closed -$218K – 4694
2017
Q1 		$218K Buy
+620
New +$139K ﹤0.01% 3780

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jane Street's NKTR Position: Q1 2026 in Review

Jane Street reduced its Nektar Therapeutics (NKTR) stake by 48% in Q1 2026, selling an estimated $6.02M and leaving 112,652 shares worth $8.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2806.

Jane Street first reported a position in NKTR in Q2 2013 and has held it in 33 quarters since. The position peaked at $16.4M in Q2 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Jane Street held 112,652 shares of Nektar Therapeutics worth $8.11M as of Q1 2026.
  • Jane Street sold 105,685 Nektar Therapeutics shares in Q1 2026, an estimated $6.02M.
  • Nektar Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2806 holding.
  • Jane Street first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 33 quarters since.
  • Jane Street's Nektar Therapeutics position peaked at $16.4M in Q2 2018.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.